{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:10:31Z","timestamp":1789765831104,"version":"4.0.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1986,3,1]],"date-time":"1986-03-01T00:00:00Z","timestamp":510019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1986,3,1]],"date-time":"1986-03-01T00:00:00Z","timestamp":510019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1986,3,1]],"date-time":"1986-03-01T00:00:00Z","timestamp":510019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1986,3,1]],"date-time":"1986-03-01T00:00:00Z","timestamp":510019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[1986,3]]},"DOI":"10.1007\/bf00152711","type":"journal-article","created":{"date-parts":[[2004,12,9]],"date-time":"2004-12-09T22:34:52Z","timestamp":1102631692000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Ribavirin: A clinical overview"],"prefix":"10.1007","volume":"2","author":[{"given":"H.","family":"Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF00152711_CR1","first-page":"43","volume-title":"Ribavirin: A Broad Spectrum Antiviral Agent","author":"L.B. Allen","year":"1980","unstructured":"Allen, L.B., (1980): Review of In Vivo Efficacy of Ribavirin. In: Smith, R.A., Kirkpatrick, W. (eds.), Ribavirin: A Broad Spectrum Antiviral Agent. -Academic Press, London, New York, pp. 43\u201358."},{"key":"BF00152711_CR2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1749-6632.1977.tb21957.x","volume":"284","author":"L.B. Allen","year":"1977","unstructured":"Allen, L.B., Wolf, S.M., Hintz, C.J., Huffman, J.H., Siduwell, R.W. (1977): Effect of Ribavirin on Type 2 Herpesvirus hominis (HVH\/2) In Vitro and In Vivo. - Ann. N.Y. Acad. Sci., 284: 247\u2013253.","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"BF00152711_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jac\/1.suppl_4.49","volume":"1","author":"G. Appleyard","year":"1975","unstructured":"Appleyard, G., Maber, H.B. (1975): A Plaque Assay for the Studv of Infuenza Virus Inhibitors. - J. Antimicrob. Chemother. [Suppl.], 1: 49\u201353.","journal-title":"J. Antimicrob. Chemother."},{"key":"BF00152711_CR4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AAC.12.1.40","volume":"12","author":"I.B. Arensman","year":"1977","unstructured":"Arensman, I.B., Dominik, J.W., Hilmas, D.E., (1977): Effects of Small-Particle Aerosols of Rimantadine and Ribavirin on Arterial Blood pH and Gas Tensions and Lung Water Content of A2 Influenza-Infected Mice. - Antimicrob. Agents Chemother., 12: 40\u201346.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF00152711_CR5","first-page":"203","volume-title":"Clinical Applications of Ribavirin","author":"G. Banks","year":"1984","unstructured":"Banks, G., Fernandez, H. (1984): Clinical Use of Ribavirin in Measles: A Summarized Review. In: Smith, R.A., Knight, V., Smith, J.A.D. (eds.), Clinical Applications of Ribavirin. - Academic Press, New York, pp. 203\u2013209."},{"key":"BF00152711_CR6","first-page":"631","volume":"36","author":"J.G. Bekesi","year":"1976","unstructured":"Bekesi, J.G., Roboz, J.P., Zimmerman, E., HollandJ.F. (1976): Treatment of Spontaneous Leukemia in AKR Mice with Chemotherapy, Immunotherapy, or Interferon. - Cancer Res., 36: 631\u2013639.","journal-title":"Cancer Res."},{"key":"BF00152711_CR7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000237969","volume":"27","author":"S.M. Bierman","year":"1981","unstructured":"Bierman, S.M., Kirkpatrik, W., Fernandez, H. (1981): Clinical Efficacy of Ribavirin in the Treatment of Genital Herpes Simplex Virus Infection. -Chemotherapy, 27: 139\u2013145.","journal-title":"Chemotherapy"},{"key":"BF00152711_CR8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/AAC.15.6.747","volume":"15","author":"M.J. Browne","year":"1979","unstructured":"Browne, M.J. (1979): Mechanism and Specificity of Action of Ribavirin. - Antimicrob. - Agents Chemother., 15: 747\u2013753.","journal-title":"Antimicrob. - Agents Chemother."},{"key":"BF00152711_CR9","first-page":"1370","volume-title":"Current Chemotherapy and Infectious Disease","author":"P.G. Canonico","year":"1980","unstructured":"Canonico, P.G., Little, J.S.Jahrling, P.B., StephenE.L. (1980): Molecular Aspects of the Antiviral Activity of Ribavirin on Venezuelan Equine Encephalomyelitis Virus. In: Nelson, J.D., Grassi, C., (eds.), Current Chemotherapy and Infectious Disease. - Am. Soc. Microbial., Washington, pp. 1370\u20131372."},{"key":"BF00152711_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-3-642-68946-8_11","volume-title":"Antibiotics, Modes and Mechanisms of Microbial Growth Inhibitors","author":"P.G. Canonico","year":"1983","unstructured":"Canonico, P.G. (1983): Ribavirin: A review of Efficacy, Toxicity and Mechanisms of Antiviral Activity. In: (F.E. Hahn ed.), Antibiotics, Modes and Mechanisms of Microbial Growth Inhibitors. -Spiringer-Verlag, Berlin, vol. 6, pp. 161\u2013186."},{"key":"BF00152711_CR11","first-page":"65","volume-title":"Clinical applications of ribavirin","author":"P.G. Canonico","year":"1984","unstructured":"Canonico, P.G., Kende, M., Huggins, J.W. (1984): The Toxicology and Pharmacology of Ribavirin in Experimental Animals. In: Smith, R.A., Knight V., Smith, J.A.D. (eds), Clinical applications of ribavirin. - Academic Press, New York, pp. 65\u201378."},{"key":"BF00152711_CR12","first-page":"83","volume-title":"Ribavirin: A Broad Spectrum Antiviral Agent","author":"D.M. Catlin","year":"1980","unstructured":"Catlin, D.M., Smith, R.A.Samuels, A.I. (1980): 14C Ribavirin: Distribution and Pharmacokinetic Studies in Rats, Baboons and Man: In: Smith, R.A., Kirckpatrick, W. (eds), Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, New York, pp. 83\u201398."},{"key":"BF00152711_CR13","doi-asserted-by":"crossref","first-page":"A114","DOI":"10.1093\/infdis\/133.Supplement_2.A114","volume":"1335","author":"A. Cohen","year":"1976","unstructured":"Cohen, A., Togo, Y., Khakoo, R.et al. (1976): Comparative Clinical and Laboratory Evaluation of the Prophylactic Capacity of Ribavirin, Amantidine Hhdrochloride, and Placebo in Induced Human Infuenza Type A. - J. Infect. Dis., 1335: A114\u201320.","journal-title":"J. Infect. Dis."},{"key":"BF00152711_CR14","first-page":"185","volume-title":"Ribavirin: A Broad Spectrum Antiviral Agent","author":"J.D. Connor","year":"1980","unstructured":"Connor, J.D., Minkoff, D.I. (1980): Clinical Use of Ribavirin and the Treatment of Herpes Zoster in Otherwise Normal Adults. In: Smith, R.A., Kirkpatrick, W. (eds), Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, New York, pp. 185\u2013199."},{"key":"BF00152711_CR15","first-page":"107","volume-title":"Clinical Applications of Ribavirin","author":"J.D. Connor","year":"1984","unstructured":"Connor, J.D., Hintz, M., VanDyke, R., McCormickJ.B., McIntosh, K. (1984): Ribavirin Pharmacokinetics in Children and Adults During Therapeutic Trials. In: Smith, R.A., Knight, V., Smith J.A.D. (eds), Clinical Applications of Ribavirin. -Academic Press, New York, pp. 107\u2013123."},{"key":"BF00152711_CR16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3181\/00379727-151-39241","volume":"151","author":"E. De Clercq","year":"1976","unstructured":"DeClercq, E., Luczak, M., Shugar, D., TorrenceP.F., Waters, J.A., Witkop, B. (1976): Effect of Cytosine Arabinoside, Iododeoxyuridine, Ethyldeoxyuridine, Thiocyanatofeoxyuridine, and Ribavarin on Tail Lesion Formation in Mice Inflected with Vaccinia Virus. - Proc. Soc. Exp. Biol. Med., 151: 487\u2013490.","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BF00152711_CR17","first-page":"354","volume-title":"Current Chemotherapy","author":"J. Descamps","year":"1977","unstructured":"Descamps, J., DeClercq, E. (1977): Broad Spectrum Antiviral Activity of Pyrazofurin (Pyrazomycin). In: Siegenthaler, W., Luthy, R. (eds), Current Chemotherapy.- Am. Soc. Microbiol., Washington, 1: 354\u2013357."},{"key":"BF00152711_CR18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1128\/AAC.10.5.809","volume":"10","author":"J.N. Dowling","year":"1976","unstructured":"Dowling, J.N., Postic, B., Guevarra, L.O. (1976): Effect of Ribavirin on Murine Cytomegalovirus Infection. - Antimicrob. Agents Chemother., 10: 809\u2013813.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF00152711_CR19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1128\/AAC.7.5.582","volume":"7","author":"F.E. Durr","year":"1975","unstructured":"Durr, F.E., Lindh, H.F., (1975): Efficacy of 1-\u03b2-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide Against Influenza Virus Infections in Mice. - Antimicrob. Agents Chemother., 7: 582\u2013586.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF00152711_CR20","first-page":"124","volume":"3","author":"G.A. Eddy","year":"1981","unstructured":"Eddy, G.A., Peters, C.J., Meadors, G., Cole, F.E.Jr. (1981): Rift Valley Fever Vaccine for Humans. -Contrib. Epidemiol. Biostatist., 3: 124\u2013141.","journal-title":"Contrib. Epidemiol. Biostatist."},{"key":"BF00152711_CR21","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3382\/ps.0531533","volume":"53","author":"C.S. Eidson","year":"1974","unstructured":"Eidson, C.S., Than, V.T., Kleven, S.H. (1974): The In Vitro and In Vivo Effect of Chemotherapeutic Agents on the Marek's Disease Herpesvirus of Chickens. - Poultry Sci., 53: 1533\u20131538.","journal-title":"Poultry Sci."},{"key":"BF00152711_CR22","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1128\/AAC.11.6.946","volume":"11","author":"B. Eriksson","year":"1977","unstructured":"Eriksson, B., Helgstrand, E., Johansson, N.G., Larsson, A., Misirony, A., Noren, J.O., Philipson, L., Stenberg, K., Stening, G., Stridh, S., Oberg, B. (1977): Inhibition of Infuenza Virus Ribonucleic Acid Polymerase by Ribavirin Triphosphate. - Antimicrob. Agents Chemother., 11: 946\u2013951.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF00152711_CR23","first-page":"245","volume":"92","author":"S. Esper-Dib","year":"1977","unstructured":"Esper-Dib, S., Scholz, I., Arroyo, C. (1977): Tratamiento de la Gingivoestomatitis Herpetiica \u2014Estudio Doble Ciego Entre Ribavirin y Placebo. -Sem. Med., 92: 245\u2013250.","journal-title":"Sem. Med."},{"key":"BF00152711_CR24","first-page":"215","volume-title":"Ribavirin: A broad spectrum antiviral agent","author":"H. Fernandez","year":"1980","unstructured":"Fernandez, H. (1980): Ribavirin: A Summary of Clinical Trials - Herpes Genitalis and Maesles. In: Smith, R.A., Kirkpatrick, W. (eds), Ribavirin: A broad spectrum antiviral agent. - Academic Press, London, New York, pp. 215\u2013230."},{"key":"BF00152711_CR25","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4269\/ajtmh.1970.19.670","volume":"19","author":"J.D. Frame","year":"1970","unstructured":"Frame, J.D., Baldwin, J.M.Jr., Gocki, D.J. and Troup, J.M. (1970): Lassa Fever, a New Virus Disease of Man From West Africa. I. Clinical Description and Pathologic Findings. - Am. J. Trop. Med. Hyg., 19: 670\u2013676.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BF00152711_CR26","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1749-6632.1977.tb21961.x","volume":"284","author":"P.A.A. Galvao","year":"1977","unstructured":"Galvao, P.A.A., Castro, I.O. (1977): Ann. N.Y. Acad. Sci., 284: 278\u2013283.","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"BF00152711_CR27","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(83)92265-1","volume":"2","author":"E.W. Gelfand","year":"1983","unstructured":"Gelfand, E.W., McCurdy, D., Pander, Rao, C., Middleton, P.J. (1983): Ribavirin Treatment of Viral Pneumonitis in Severe Combined Immunodeficiency Disease. - Lancet, 2: 732\u2013733.","journal-title":"Lancet"},{"key":"BF00152711_CR28","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/0006-291X(79)91853-9","volume":"89","author":"B.B. Goswami","year":"1979","unstructured":"Goswami, B.B., Borek, E., Sharma, O.K., Fujitaki, J., Smith, R.A. (1979): The Broad Spectrum Antiviral Agent Ribavirin Inhibits Capping of mRNA. -Biochem. Biophys. Res. Commun., 89: 830\u2013836.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF00152711_CR29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/978-3-642-46407-2_22","volume-title":"Mechanism of Action of Antieukaryotic and Antiviral Compounds","author":"F.E. Hahn","year":"1979","unstructured":"Hahn, F.E. (1979): Virazole (ribavirin). In: Hahn F.E. (ed), Mechanism of Action of Antieukaryotic and Antiviral Compounds. Springer, Berlin, Heidelberg, New York, 2: 439\u2013456."},{"issue":"19","key":"BF00152711_CR30","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1001\/jama.1983.03330430042027","volume":"249","author":"C.B. Hall","year":"1983","unstructured":"Hall, C.B., Walsh, E.E., Hruska, J.F., Betts, R.F., HallW.J. (1983): Ribavirin Treatment of Experimental Respiratory Syncytial Viral Infection. - J. Amer. Med. Assoc., 249(19): 2666\u20132670.","journal-title":"J. Amer. Med. Assoc."},{"issue":"24","key":"BF00152711_CR31","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJM198306163082403","volume":"308","author":"C.B. Hall","year":"1983","unstructured":"Hall, C.B., McBride, J.T., Walsh, E.E., Bell, D.M., Gala, C., Hildreth, S., Ten Eyck, L.G., Hall, W.J. (1983): Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral Infection.- N. Engl. J. Med., 308(24): 1443\u20131447.","journal-title":"N. Engl. J. Med."},{"key":"BF00152711_CR32","first-page":"1","volume-title":"Ribavirin: A Broad Spectrum Antiviral Agent","author":"S. Harris","year":"1980","unstructured":"Harris, S., Robins, R.K. (1980): Ribavirin: Structure and Antiviral Activity Relationships. In: Smith R.A., Kirkpatrick, W. (eds), Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, London, New York, pp. 1\u201321."},{"key":"BF00152711_CR33","first-page":"59","volume-title":"Ribavirin: A Broad Spectrum Antiviral Agent","author":"I.W. Hillyard","year":"1980","unstructured":"Hillyard, I.W. (1980): The preclinical toxicology and safety of ribavirin. In: Smith, R.A., Kirkpatrick W. (eds) Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, New York, pp. 59\u201372."},{"key":"BF00152711_CR34","unstructured":"Hoffmann S.H. (1985) : Personal Communication."},{"key":"BF00152711_CR35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/AAC.3.2.235","volume":"3","author":"J.H. Huffman","year":"1973","unstructured":"Huffman, J.H., Sidwell, R.W., Khare, G.P.WitkowskiJ.T., Allen, L.B.Robins, R.K. (1973): In vitro effect of 1-\u03b2-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Deoxribonucleic Acid and Ribonucleic Acid Viruses. - Antimicrob. Agents Chemother., 3: 235\u2013241.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF00152711_CR36","unstructured":"Huggins D., Pereira G.J.M. (1977): Rev. Bras. Med., 34 (5)."},{"key":"BF00152711_CR37","first-page":"49","volume-title":"Clinical Applications of Ribavirin","author":"J.M. Huggins","year":"1984","unstructured":"Huggins, J.M., Jahrling, P., Kende, M. and CanonicoP.G. (1984): Efficacy of Ribavirin Against Virulent RNA Virus Infections. In: Smith, R.A., Knight, V. and Smith, J.A.D. (eds), Clinical Applications of Ribavirin. - Academic Press, New York, pp. 49\u201363."},{"key":"BF00152711_CR38","first-page":"340","volume-title":"Current Chemotherapy","author":"P. Jacobi","year":"1977","unstructured":"Jacobi, P., Hoffman, K., Arend, P., Muckter, H. (1977): In vivo evaluation of the Antiviral Efficacy of Ribavirin Against Influenza, Hepatitis, Herpes, and Vaccinia Infections in Mice. In: Siegenthaler W., Luthy, R. (eds), Current Chemotherapy. - Am. Soc. Microbiol., Washington, 1: 340\u2013343."},{"key":"BF00152711_CR39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/infdis\/141.5.580","volume":"141","author":"P.B. Jahrling","year":"1980","unstructured":"Jahrling, P.B., Hesse, R.A., Eddy, G.A., Johnson, K.M., Callis, R.T., Stephen, E.L. (1980): Lassa Virus Infection In Rhesus Monkeys: Pathogenesis and Treatment with Ribavirin. - J. Infect. Dis., 141: 580\u2013589.","journal-title":"J. Infect. Dis."},{"key":"BF00152711_CR40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/infdis\/149.3.420","volume":"149","author":"P.B. Jahrling","year":"1984","unstructured":"Jahrling, P.B., Peters, J., and Stephen, E.L. (1984): Enhanced Treatment of Lassa Fever by Immune Plasma Combined With Ribavirin in Cynomolgus Monkeys. - J. Infect. Dis., 149: 420\u2013427.","journal-title":"J. Infect. Dis."},{"key":"BF00152711_CR41","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jac\/4.4.367","volume":"4","author":"S. Jain","year":"1978","unstructured":"Jain, S., Thomas, H.C., Oxford, J.S., Sherlock, S. (1978): J. Antimicrob. Chemoth., 4: 376\u2013373.","journal-title":"J. Antimicrob. Chemoth."},{"key":"BF00152711_CR42","first-page":"93","volume-title":"Clinical Applications of Ribavirin","author":"W.B. Jolley","year":"1984","unstructured":"Jolley, W.B., Suchil, C. (1984): Effects of Ribavirin on the Immune System (second Report). In: Smith, R.A., Knight, V., Smith, J.A.D. (eds), Clinical Applications of Ribavirin. - Academic Press, New York, pp. 93\u201396."},{"key":"BF00152711_CR43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1099\/0022-1317-32-2-327","volume":"32","author":"E. Katz","year":"1976","unstructured":"Katz, E., Margalith, E., Winer, B. (1976): Inhibition of Vaccinia Virus Growth by the Nucleoside Analogue 1-\u03b2-D-Ribofuranosyl-1, 2, 4-Triazole-3-Carboxamide (Virazole, Ribavirin). J. Gen. Virol., 32: 327\u2013330","journal-title":"J. Gen. Virol."},{"key":"BF00152711_CR44","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1128\/AAC.3.4.517","volume":"3","author":"G.P. Khare","year":"1973","unstructured":"Khare, G.P., Sidwell, R.W., Witkowski, J.T., SimonL.M., Robins, R.K. (1973): Suppression by 1-\u03b2-D-Ribofurano:syl-1, 2, 4-Triazole-3-Carboxamide (Virazole, ICN 1229) of Influenza Virus-Induced Infections in Mice. - Antimicrob. Agents Chemother, 3: 517\u2013522.","journal-title":"Antimicrob. Agents Chemother"},{"key":"BF00152711_CR45","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(81)91152-1","volume":"2","author":"V. Knight","year":"1981","unstructured":"Knight, V., McClung, H.W., Wilson, S.Z., Waters, B.K., Qualers, J.M., Cameron, R.W., Greggs, S.E., ZerwasJ.M., Couch, R.B. (1981): Ribavirin Small-Particle Aerosol Treatment of Influenza. - Lancet, 2: 945\u2013949.","journal-title":"Lancet"},{"key":"BF00152711_CR46","first-page":"99","volume":"20","author":"N.B. Kumta","year":"1983","unstructured":"Kumta, N.B., Antani, D.N. (1983): Pediatrics, 20: 99\u2013103.","journal-title":"Pediatrics"},{"key":"BF00152711_CR47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/AAC.13.2.154","volume":"13","author":"A. Larsson","year":"1978","unstructured":"Larsson, A., Stenberg, K., Oberg, B. (1978): Reversible Inhibition of Cellular Metabolism by Ribavirin. - Antimicrob. Agents Chemother, 13: 154\u2013158.","journal-title":"Antimicrob. Agents Chemother"},{"key":"BF00152711_CR48","unstructured":"Latonio A.A., Limson B.M., Ramos T.T. (1978): On File at Viratek, Inc."},{"key":"BF00152711_CR49","first-page":"401","volume":"33","author":"R. Lorenco","year":"1977","unstructured":"Lorenco, R., Camargo, M.J., Castro, I.O. (1977): Revista Medica Brasileira, 33: 401\u2013403.","journal-title":"Revista Medica Brasileira"},{"key":"BF00152711_CR50","first-page":"736","volume":"37","author":"J.K. Lowe","year":"1977","unstructured":"Lowe, J.K., Brox, L., Henderson, J.F. (1977): Consequences of Inhibition of Guanine Nucleotide Synthesis by Mycophenolic Acid and Virazole. - Cancer Res., 37: 736\u2013743.","journal-title":"Cancer Res."},{"key":"BF00152711_CR51","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/AAC.12.4.498","volume":"12","author":"C.R. Magnussen","year":"1977","unstructured":"Magnussen, C.R., Douglas, R.G., Betts, R.F., RothF.K., Meagher, M.P. (1977): Double-Blind Evaluation of Oral Ribavirin (Virazole) in Experimental Influenza A Virus Infection in Volunteers. - Antimicrob. Agents Chemotehr., 12: 498\u2013502.","journal-title":"Antimicrob. Agents Chemotehr."},{"issue":"19","key":"BF00152711_CR52","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1001\/jama.1983.03330430047028","volume":"249","author":"H.W. Mc Clung","year":"1983","unstructured":"Mc Clung, H.W., Knight, V., Gilbert, B.E., WilsonS.Z., Quarles, J.M., Divine, G.W. (1983): Ribavirin Aerosol Treatment of Influenza B Virus Infection.- J. Amer. Med. Assoc., 249(19): 2671\u20132674.","journal-title":"J. Amer. Med. Assoc."},{"key":"BF00152711_CR53","first-page":"213","volume-title":"Ribavirin: A Broad Spectrum Antiviral Agent","author":"J.B. McCorinick","year":"1980","unstructured":"McCorinick, J.B., Webb, P.A., Johnson, K.M., (1980): Lassa Immune Plasma and Ribavirin in the Therapy of Acute Lassa Fever. In: Smith, R.A., Kirkpatrick W. (eds), Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, London, New York, p. 213."},{"key":"BF00152711_CR54","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(84)92060-9","volume":"ii","author":"J.B. McCormick","year":"1984","unstructured":"McCormick, J.B., Getchell, J.P., Mitchell, S.W.et al. (1984): Ribavirin Suppress Replication of Lymphadenopathy-Associated Virus in Cultures of Human Adult T Lymphocytes. - Lancet, ii: 1367\u201369.","journal-title":"Lancet"},{"key":"BF00152711_CR55","first-page":"49","volume-title":"Clinical Application of Ribavirin","author":"J.B. McCormick","year":"1984","unstructured":"McCormick, J.B.Webb, P.A., Johnson, K.M. and Scribner, C.S. (1984): Chemotherapy of Acute Lassa Fever with Ribavirin. In: Smith, R.A., Knight, V., Smith, J.A.D. (eds). Clinical Application of Ribavirin.- Accademic Press, New York, pp. 49\u201363."},{"key":"BF00152711_CR56","unstructured":"McCormick J.B., King I., Webb P.A., Johnson K.M. and Scribner C.S., Smith E.S., Craven R.B., O-Sullivan R. and Belmont-Williams R. (1985): Lassa Fever: Efficacy of Therapy with Ribavirin. - N. Engl. J. Med., (in press)."},{"key":"BF00152711_CR57","unstructured":"McCormick J.B et al. (1985): J. of Infect Dis., (in press)."},{"key":"BF00152711_CR58","first-page":"305","volume":"138","author":"K. McIntosh","year":"1984","unstructured":"McIntosh, K., Kurachek, S.C., Cairns, L.M., BurnsJ.C., Goodspeed, B. (1984): Treatment of Respiratory Viral Infection in an Immunodeficient Infant with Ribavirin Aerosol. - Amer. J. Dis. Children, 138: 305\u2013308.","journal-title":"Amer. J. Dis. Children"},{"key":"BF00152711_CR59","first-page":"11","volume":"25","author":"G. Menzell","year":"1978","unstructured":"Menzell, G., Steuz, E. (1978): Wirkungen Von Virazole (Ribavirin) in Virus-Prokaryonten-Systemen.- Acta. Microbiol. Acad. Sci. Hung., 25: 11\u201315","journal-title":"Acta. Microbiol. Acad. Sci. Hung."},{"key":"BF00152711_CR60","doi-asserted-by":"crossref","first-page":"773","DOI":"10.4269\/ajtmh.1973.22.773","volume":"22","author":"T.P. Monath","year":"1973","unstructured":"Monath, T.P., Mertens, P.E., Patton, R., Moser, C.R., Baum, J.J., Pinneo, L., Gary, G.W.Jr. and KisslingR.E. (1973): A Hospital Epidemic of Lassa Fever in Zorzor, Liberia, March-April, 1972. - Am. J. Trop. Med. Hyg., 22: 773\u2013780.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BF00152711_CR61","unstructured":"Mosley J.W., Redeker A.G. (1974): On File at Viratek, Inc."},{"key":"BF00152711_CR62","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0006-2952(77)90246-5","volume":"26","author":"E.W.G. Muller","year":"1977","unstructured":"Muller, E.W.G., Maidhof, A., Taschner, H., Zahn, R.K. (1977): Virazole (1-\u03b2-D-Ribofuranosly-1, 2, 4-Triazole-3-Carboxamide) a Cytostatic Agent. - Biochem. Pharmacol., 26: 1071\u20131075.","journal-title":"Biochem. Pharmacol."},{"key":"BF00152711_CR63","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0021-9258(17)34923-2","volume":"253","author":"S. Muthukrishnan","year":"1978","unstructured":"Muthukrishnan, S., Moss, B., Cooper, J.A., MaxwellE.S. (1978): Influence of 5\u2032-Terminal Cap Structure on the Initiation of Translation of Vaccinia Virus mRNA. - J. Biol. Chem., 253: 1710\u20131715.","journal-title":"J. Biol. Chem."},{"key":"BF00152711_CR64","first-page":"148","volume":"17","author":"H. Nishimura","year":"1964","unstructured":"Nishimura, H., Mayama, M., Komatsu, Y., Kato, H., Shimaoka, N., Tanaka, Y., (1964): Showdomycin, a New Antibiotic From a Streptomyces Sp. - J. Antibiot., 17: 148\u2013155.","journal-title":"J. Antibiot."},{"key":"BF00152711_CR65","first-page":"334","volume-title":"Current Chemotherapy","author":"H.A. Odelola","year":"1977","unstructured":"Odelola, H.A. (1977): Antiviral Activity of Virazole on Replication of Viruses Isolated in Nigeria. In: Siegenthaler, W., Luthy, R. (eds), Current Chemotherapy.- Am. Soc. Microbiol., Washington, vol. 1, pp. 334\u2013335."},{"key":"BF00152711_CR66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/1.1.7","volume":"1","author":"J.S. Oxford","year":"1975","unstructured":"Oxford, J.S. (1975): Specific Inhibitors of Influenza Virus Replication as Potential Chemoprophylactic Agents. - J. Antimicrob. Chemother., 1: 7\u201323.","journal-title":"J. Antimicrob. Chemother."},{"key":"BF00152711_CR67","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000238094","volume":"28","author":"A.S. Patki","year":"1982","unstructured":"Patki, A.S., Gupta, P. (1982): Chemotherapy, 28: 298\u2013303.","journal-title":"Chemotherapy"},{"key":"BF00152711_CR68","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/259496a0","volume":"259","author":"C.W. Potter","year":"1976","unstructured":"Potter, C.W., Phair, J.P., Vodinelich, L., Fenton, R., Jennings, R. (1976): Antiviral Immunosuppressive and Antitumor Effects of Ribavirin. - Nature, 259: 406\u2013497.","journal-title":"Nature"},{"key":"BF00152711_CR69","first-page":"175","volume":"39","author":"R.C. Povey","year":"1978","unstructured":"Povey, R.C. (1978): In Vitro Antiviral Efficacy of Ribavirin Against Feline Calicivirus, Feline Viral Rhinotracheitis Virus, and Canine Parainfluenza Virus. - Am. J. Vet. Res., 39: 175\u2013178.","journal-title":"Am. J. Vet. Res."},{"key":"BF00152711_CR70","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01314381","volume":"54","author":"H.E. Renis","year":"1977","unstructured":"Renis, H.E. (1977): Influenza Virus Infection of Hamsters. A Model for Evaluating Antiviral Drugs.- Arch. Virol., 54: 85\u201393.","journal-title":"Arch. Virol."},{"key":"BF00152711_CR71","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1749-6632.1977.tb21960.x","volume":"284","author":"F. Salido-Rengell","year":"1977","unstructured":"Salido-Rengell, F., Nasser-Quinones, H., Briseno-GarciaB. (1977): Clinical Evaluation of 1-\u03b2-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Ribavirin) in a Double Blind Study During an Outbreak of Influenza. - Ann. N.Y. Sci., 284: 272\u201327.","journal-title":"Ann. N.Y. Sci."},{"key":"BF00152711_CR72","first-page":"106","volume":"19","author":"P. Scheffler","year":"1975","unstructured":"Scheffler, P., Haghchenas, D., Wigand, R. (1975): The Effect of Purine and Pyrimidine Analogues and Virazole on Adenovirus Replication. - Acta. Virol., 19: 106\u2013115.","journal-title":"Acta. Virol."},{"key":"BF00152711_CR73","first-page":"145","volume-title":"Clinical Applications of Ribavirin","author":"G.M. Schiff","year":"1984","unstructured":"Schiff, G.M., Stephens, K., Brooks, S., Cassidy, K., Odeski, R., Majors, M. (1984): Small Particle Aerosol of Ribavirin in the Therapy of Influenza \u2014Cincinnati Study. In: Smith, R.A., Knight, V., and Smith, J.A.D. (eds), Clinical Applications of Ribavirin.- Academic Press, New York, pp. 145\u2013153."},{"key":"BF00152711_CR74","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jac\/1.suppl_4.63","volume":"1","author":"K.P. Schofield","year":"1975","unstructured":"Schofield, K.P., Potter, C.W., Edey, D., Jennings, R., Oxford, J.S. (1975): Antiviral Activity of Ribavirin on Influenza Infection in Ferrets. - J. Antimicrob. Chemother. [Suppl], 1: 63\u201369.","journal-title":"J. Antimicrob. Chemother."},{"key":"BF00152711_CR75","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1128\/AAC.12.4.543","volume":"12","author":"B.D. Schoub","year":"1977","unstructured":"Schoub, B.D., Prozesky, O.W. (1977): Antiviral Activity of Ribavirin in Rotavirus Gastroenteritis of Mice. - Antimicrob. Agents Chemoter., 12: 543\u2013544.","journal-title":"Antimicrob. Agents Chemoter."},{"key":"BF00152711_CR76","first-page":"79","volume-title":"Ribavirin: A Broad Spectrum Antiviral Agent","author":"N.R. Schulman","year":"1984","unstructured":"Schulman, N.R. (1984): Assessment of Hematologic Effects of Ribavirin in Humans. In: Smith, R.A., Kirkpatrick, W., (eds), Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, New York, pp. 79\u201392."},{"key":"BF00152711_CR77","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1749-6632.1977.tb21983.x","volume":"284","author":"W.M. Shannon","year":"1977","unstructured":"Shannon, W.M. (1977): Selective Inhibition of RNA Tumor Virus Replication In Vitro and Evaluation of Candidate Antiviral Agents In Vivo. - Ann. N.Y. Acad. Sci., 284: 472\u2013507.","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"BF00152711_CR78","first-page":"318","volume":"97","author":"H. Shiota","year":"1977","unstructured":"Shiota, H., Jones, B.R., Schaffner, C.P. (1977): Potential Role of Amphotericin B. Methyl Ester in the Prevention and Therapy of Herpetic Keratitis.- Trans. Opthalmol. Soc. U.K., 97: 318\u2013323.","journal-title":"Trans. Opthalmol. Soc. U.K."},{"key":"BF00152711_CR79","first-page":"367","volume-title":"New Trends in Microbiology","author":"R.W. Sidwell","year":"1977","unstructured":"Sidwell, R.W. (1977): Ribavirin: A Broad Spectrum Antiviral Having Clinical Usefulness. In: Likar M., (ed), New Trends in Microbiology. - Ljubljiana, Yugoslavia: Society of Yugoslav Microbiologists, pp. 367\u2013400."},{"key":"BF00152711_CR80","first-page":"23","volume-title":"Ribavirin: A Broad Spectrum Antiviral Agent","author":"R.W. Sidwell","year":"1980","unstructured":"Sidwell, R.W. (1980): Ribavirin: In Vitro Antiviral Activity. In: Smith, R.A., Kirkpatrick, W., (eds), Ribavirin: A Broad Spectrum Antiviral Agent. -Academic Press, London, New York, pp. 23\u201342."},{"key":"BF00152711_CR81","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.177.4050.705","volume":"177","author":"R.W. Sidwell","year":"1972","unstructured":"Sidwell, R.W., Huffman, J.H., Kahre, G.P., Allen, L.B., Witkowski, J.T., Robins, R.K. (1972): Broad Spectrum Antiviral Activity of Virazole: 1-\u03b2-D-Ribofuranosyl-1, 2, 4-Triazole-3-Carboxamide.- Science, 177: 705\u2013706.","journal-title":"Science"},{"key":"BF00152711_CR82","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/AAC.3.2.242","volume":"3","author":"R.W. Sidwell","year":"1973","unstructured":"Sidwell, R.W., Allen, L.B., Khare, G.P., Huffman, J.H., Witkowski, J.T., Simon, L.N., Robins, R.K. (1973): Effect of 1-\u03b2-D-Ribofuranosyl-1, 2, 4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Herpes and Vaccinia Keratitis and Encephalitis in Laboratory Animals. - Antimicrob. Agents Chemother., 3: 242\u2013246.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF00152711_CR83","first-page":"889","volume-title":"Progress in Chemotherapy","author":"R.W. Sidwell","year":"1974","unstructured":"Sidwell, R.W., Simon, L.N, Witkowski, J.T., RobinsR.K. (1974): Antiviral Activity of Virazole: Review and Structure-Activity Relationships. In: Daikos G.K. (ed), Progress in Chemotherapy. - Athens: Hellenic Society for Chemotherapy, 2: 889\u2013902."},{"key":"BF00152711_CR84","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3181\/00379727-148-38647","volume":"148","author":"R.W. Sidwell","year":"1975","unstructured":"Sidwell, R.W., Allen, L.B., Huffman, J.H., WitkowskiJ.T., Simon, L.N. (1975): Effect of 1-\u03b2-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Ribavirin) on Friend Leukemia Virus Infections in Mice. - Proc. Soc. Exp. Biol. Med. 148: 854\u2013858.","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BF00152711_CR85","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000221861","volume":"21","author":"R.W. Sidwell","year":"1975","unstructured":"Sidwell, R.W., Khare, G.P., Allen, L.B., Huffman, J.H., Witkowski, J.T., Simon, L.N., Robins, R.K. (1975): In Vitro and In Vivo Effect on 1-\u03b2-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Ribavirin) and Types 1 and 3 Parainfluenza Virus Infections.- Chemotherapy, 21: 205\u2013220.","journal-title":"Chemotherapy"},{"key":"BF00152711_CR86","first-page":"123","volume":"6","author":"R.W. Sidwell","year":"1979","unstructured":"Sidwell, R.W., Robins, R.K., Hillyard, I.W. (1979): Ribavirin: An Antiviral Agent. Pharmacol. Ther., 6: 123\u2013146.","journal-title":"Ribavirin: An Antiviral Agent. Pharmacol. Ther."},{"key":"BF00152711_CR87","first-page":"147","volume-title":"Ribavirin: A Broad Spectrum Antiviral Agent","author":"C.B. Smith","year":"1980","unstructured":"Smith, C.B., Charette, R.P., Fox, J.P.Cooney, M.K., Hall, C.E. (1980): Double-Blind Evaluation of Ribavirin in Naturally Occurring Influenza. In: Smith, R.A., Kirkpatrick, W. (eds), Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, London, New York, pp. 147\u2013164."},{"key":"BF00152711_CR88","first-page":"99","volume-title":"Ribavirin: A Broad Spectrum Antiviral Agent","author":"R.A. Smith","year":"1980","unstructured":"Smith, R.A. (1980): Mechanisms of Action of Ribavirin. In: Smith, R.A., Kirkpatrick, W. (eds), Ribavirin: A Broad Spectrum Antiviral Agent. -Academic Press, London, New York, pp. 99\u2013118."},{"key":"BF00152711_CR89","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-4613-3804-8_15","volume-title":"Antiviral Drugs and Interferon: The Molecular Basis of Their Activity","author":"R.A. Smith","year":"1984","unstructured":"Smith, R.A. (1984): Ribavirin. In: Becker, Y. (ed), Antiviral Drugs and Interferon: The Molecular Basis of Their Activity. - Martinus Nijhoff Pushing, Boston, pp. 253\u2013269."},{"key":"BF00152711_CR90","unstructured":"Smith R.A., Fernandez H., Banks G. (1985): Aerosolized Ribavirin Treatment of Immunodeficient Infants with. Respiratory Viral Infection. First International TNO Conference on Ativiral Research, Rotterdam, April 30 \u2013 May 3, 1985, (in press)."},{"key":"BF00152711_CR91","first-page":"169","volume-title":"Ribavirin: A Broad Spectrum Antiviral Agent","author":"E.L. Stephen","year":"1980","unstructured":"Stephen, E.L., Jones, D.E., Peters, C.J., Eddy, G.A., Loizeaux, P.S., Jahrling, P.B. (1980): Ribavirin Treatment of Toga-, Arena-, and Bunyavirus Infections in Subhuman Primates and Other Laboratory Animal Species. In: Smith, R.A., Kirkpatrick W. (eds), Ribavirin: A Broad Spectrum Antiviral Agent. - Academic Press, London, New York, pp. 169\u2013183."},{"key":"BF00152711_CR92","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1073\/pnas.70.4.1174","volume":"70","author":"D.G. Streeter","year":"1973","unstructured":"Streeter, D.G., Witkowski, J.T.Khare, G.P., SidwellR.W., Bauer, R.J., Robins, R.K., Simon, L.N. (1973): Mechanism of Action of 1-\u03b2-D-Ribofuranosyl-1, 2, 4-Triazole-3-Carboxamide (Virazole), A New Broad Spectrum Antiviral Agent. - Proc. Natl. Acad. Sci. U.S.A., 70: 1174\u20131178.","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"BF00152711_CR93","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1021\/bi00719a011","volume":"13","author":"D.G. Streeter","year":"1974","unstructured":"Streeter, D.G., Simon, L.N., Robins, R.H., Miller, J.P. (1974): The Phosphorylation of Ribavirin by Deoxyadenosine Kinase From Rat Liver. - Differentiation Between Adenosine and Deoxyadenosine Kinase. - Biochemistry, 13: 453\u2013459.","journal-title":"Biochemistry"},{"key":"BF00152711_CR94","first-page":"193","volume-title":"Clinical Applications of Ribavirin","author":"S.F. Suarez","year":"1984","unstructured":"Suarez, S.F.Guevara, S.I., Mijangos, V.G. (1984): Treatment of Type A Hepatitis with Ribavirin. In: Smith, R.A., Knight, V., Smith, J.A.D. (eds), Clinical Applications of Ribavirin. - Academic Press, New York, pp. 193\u2013201."},{"key":"BF00152711_CR95","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1620\/tjem.110.405","volume":"110","author":"T. Suganuma","year":"1973","unstructured":"Suganuma, T., Ishida, N. (1973): An Evaluation of a New Antiviral Agent. \u226a Virazole \u226b Against Influenza Virus Infections. - Tohoku, J. Exp. Med., 110: 405\u2013406.","journal-title":"Tohoku, J. Exp. Med."},{"key":"BF00152711_CR96","first-page":"573","volume":"18","author":"K.J. Sung","year":"1980","unstructured":"Sung, K.J.Kim, K.J., Cinn, Y.W., Kim, W.S., KimH.S., Lee, H.S. (1980): Korean J. Derm., 18: 573\u2013577.","journal-title":"Korean J. Derm."},{"issue":"5","key":"BF00152711_CR97","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1542\/peds.72.5.613","volume":"72","author":"L.H. Taber","year":"1983","unstructured":"Taber, L.H., Knight, V., Gilbert, B.E., McClung, H.W., Wilson, S.Z., Norton, H.J., Thurson, J.M., GordonW.H.Atmar, R.L., Schlaudt, W.R. (1983): Ribavirin Aerosol Treatment of Bronchiolitis Associated With Respiratory Syncytial Virus Infection in Infants. - Ped. 72(5): 613\u2013618.","journal-title":"Ped."},{"key":"BF00152711_CR98","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jac\/1.suppl_4.55","volume":"1","author":"M. Tisdale","year":"1975","unstructured":"Tisdale, M., Bauer, D.J. (1975): A Comparison of Test Methods in Influenza Chemotherapy. - J. Antimicrob. Chemotherapy. - [Suppl.], 1: 55\u201362. ther., 4: 641\u2013642.","journal-title":"J. Antimicrob. Chemotherapy."},{"key":"BF00152711_CR99","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1749-6632.1977.tb21958.x","volume":"284","author":"M. Tisdale","year":"1977","unstructured":"Tisdale, M., Bauer, D.J. (1977): The Relative Potencies of Anti-Influenza Compounds. - Ann. N.Y. Acad. Sci., 284: 254\u2013263.","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"BF00152711_CR100","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1128\/AAC.4.6.641","volume":"4","author":"Y. Togo","year":"1973","unstructured":"Togo, Y. (1973): In Vitro Effect of Virazole Against Influenza Viruses. - Antimicrob. Agents Chemother., 4: 641\u2013642.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF00152711_CR101","doi-asserted-by":"crossref","first-page":"A109","DOI":"10.1093\/infdis\/133.Supplement_2.A109","volume":"133","author":"Y. Togo","year":"1976","unstructured":"Togo, Y., McCracken, E.D. (1976): Double Blind Assessment of Ribavirin (Virazole) in the Prevention and Treatment of Induced Infection With Type B Influenza Virus. - J. Infect. Dis., [Suppl], 133: A109-A113.","journal-title":"J. Infect. Dis."},{"key":"BF00152711_CR102","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0041-008X(82)90334-9","volume":"64","author":"G.L. Wannarka","year":"1982","unstructured":"Wannarka, G.L., Stephen, E.L. and Canonico, P.G. (1982): Preclinical Evaluation in Monkeys of a Ribavirin Regimen Proposed for Use in Lassa Fever Patient. - Toxicol. Appl. Pharmacol., 64: 155\u2013169.","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"BF00152711_CR103","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0035-9203(72)90269-6","volume":"66","author":"H.A. White","year":"1972","unstructured":"White, H.A. (1972): Clinical Findings in 23 Cases of Lassa Fever Hospitalized in Jos, Nigeria, 1970. -Trans. R. Soc. Trop. Med. Hyg., 66: 390\u2013399.","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"BF00152711_CR104","volume-title":"Proc. 158th Am. Chem. Soc. Natl. Meet Abstr.","author":"R.H. Williams","year":"1969","unstructured":"Williams, R.H., Gerzon, K., Hoehn, M., Gorman, M., Delong, D.C. (1969): Pyrazofurin, a Viral Carbolinked Nucleoside. In: Proc. 158th Am. Chem. Soc. Natl. Meet Abstr. MICR 38, New York, N.Y."},{"key":"BF00152711_CR105","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1073\/pnas.75.7.3042","volume":"75","author":"R.C. Willis","year":"1978","unstructured":"Willis, R.C., Carson, D.A., Seegmiller, J.E. (1978): Adenosine Kinase Initiates the Major Route of Ribavirin Activation in a Cultured Human Cell Line. - Proc. Nat. Acad. Sci U.S.A., 75: 3042\u20133044.","journal-title":"Proc. Nat. Acad. Sci U.S.A."},{"key":"BF00152711_CR106","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1021\/jm00281a014","volume":"15","author":"J.T. Witkowsky","year":"1972","unstructured":"Witkowsky, J.T., Robins, R.K.Sidwell, R.W.SimonL.N. (1972): The Design, Synthesis and Broad Spectrum Antiviral Activity of 1-\u03b2-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide and Related Nucleosides.- J. Med. Chem., 15: 1150\u20131156.","journal-title":"J. Med. Chem."},{"key":"BF00152711_CR107","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0006-2952(78)90508-7","volume":"27","author":"T.P. Zimmerman","year":"1978","unstructured":"Zimmerman, T.P., Deeprose, R.D. (1978): Metabolism of 5-Amino-l-D-Ribofuranosylimidazole-4-Carboxamide and Related Five-Membered Heterocycles to 5\u2032-Triphosphates in Human Blood and L5178Y Cells. - Biochem. Pharmacol., 27: 709\u2013716.","journal-title":"Biochem. Pharmacol."}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00152711.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00152711\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00152711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00152711.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T14:09:30Z","timestamp":1684850970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00152711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,3]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1986,3]]}},"alternative-id":["BF00152711"],"URL":"https:\/\/doi.org\/10.1007\/bf00152711","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,3]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}